News Release

Transmissive-detected laser speckle imaging for blood flow monitoring in thick tissue

Peer-Reviewed Publication

Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CAS

TR-LSCI for animal and human applications

image: a, the diagram of transmissive-detected laser speckle contrast imaging (TR-LSCI) system. b, the diagram of conventional reflective-detected LSCI system. c, comparison between TR-LSCI and conventional LSCI for cutaneous/subcutaneous blood flow mapping on different parts of mice body. In (c), it is obvious that TR-LSCI has better imaging quality for each body parts, especially for thick parts. d, TR-LSCI for dynamic blood flow monitoring in the mice hindlimb after acetyl choline (a drug that dilates blood vessels) injection. TR-LSCI was capable of distinguishing individual cutaneous blood vessels. The plots in (d) represent the dynamics in the femoral vein and in the branch of femoral vein, which shows that, compared to femoral vein, the blood flow velocity in the branch of femoral vein responded stronger but recovered more quickly. e, comparison between TR-LSCI and conventional LSCI for subcutaneous blood flow mapping on different parts of human hands. As shown in (e), the blood flow in the individual blood vessels was resolvable in TR-LSCI, while conventional LSCI was not able to distinguish. f, conventional LSCI and TR-LSCI for reactive hyperemia experiments on human hands. Conventional LSCI was used to monitor superficial perfusion, while TR-LSCI was used to monitor blood flow in the deep vessels. The histograms in (f) represent the dynamics in the superficial perfusion and deep blood flow. The results suggested that blood flow in the deep larger vessels was more affected by pressure and recovered more slowly after pressure was released. view more 

Credit: by Dong-Yu Li, Qing Xia, Ting-Ting Yu, Jing-Tan Zhu, and Dan Zhu

Blood flow velocity is an important parameter reflecting vascular function. Abnormal vascular function is closely related to the occurrence and development of many diseases, such as diabetes, arteriosclerosis, thrombosis and so on. Therefore, the monitoring of flow velocity is not only an important research target, but also an important clinical indicator.

Laser speckle contrast imaging (LSCI) is a wide-field, noninvasive imaging technique with high temporal and spatial resolution, which is based on the analysis of light signals after scattering and random interference, and therefore obtains the velocity information of scattering particles in biological tissues (e.g., red blood cells), and has been widely used in the research of vascular functions. However, the deep signals were hardly detectable for conventional without windows model because it works on the reflective-detected mode, therefore the strength of static speckle in the upper layer is much greater than that of dynamic speckle signal in the deep targeted blood vessels, leading to a low signal-to-background ratio (SBR).

In a new paper published in Light Science & Application, Dan Zhu’s group from Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, China, have greatly improved the imaging ability of laser speckle imaging on thick tissue by changing the detection methods of laser speckle imaging. Using transmission detection method, the dynamic speckle signals from the vascular layer become stronger than the static speckle information from the upper tissue layer, thus improving the SBR of thick-tissue blood flow detection.

In previous studies, conventional reflective-detected LSCI could obtain high-resolution images of blood flow distribution in experimental animals only when combined with "surgical windows" or "tissue optical clearing windows". However, in the human experiment, the image resolution is extremely low because a “tissue window” cannot be performed. On the contrary, the authors of this paper used TR-LSCI to perform cutaneous/subcutaneous blood flow mapping and tracking in various mouse body parts, including the ear, hindlimb, back and paw, without any skin window. More importantly, TR-LSCI was capable of monitoring adult human blood flow changes in fingers or palms with individual-vessel resolution, and the imaging procedure didn’t need much laser irradiation (6 mJ/cm2), “which was much lower than that used in low-level-laser therapy.” The scientists said.

Using their system, the scientists studied the difference of the response between blood flow in deep tissue and perfusion in the superficial layer and found: “Compared to the perfusion in the superficial layer, where there was almost microvasculature, blood flow in the deep larger vessels was more affected by pressure and recovered more slowly after pressure was released.”

Thanks to its noninvasiveness, low cost, and high temporal-spatial resolution, TR-LSCI holds great potential in the field of microcirculation research. These scientists envision the future applications for the technology:

“Our systematical in vivo results also suggested that TR-LSCI could perform blood flow mapping with promising resolution in thick tissue without the assistance of tissue windows, those conventional LSCI needs for the research of tumor vasculature, wound healing, therapeutic effect of thrombolytic drugs, photodynamic therapy of malformed blood vessels and so on.”

“The successful acquirement of blood flow signal in human hand implied that TR-LSCI might be further applied in other human body parts whose thickness is feasible for light to penetrate, such as ear, lip, toe, and instep etc. Thus, the development of TR-LSCI might accelerate the clinical research of microcirculation and related diseases, such as diabetic foot ulcer, rheumatoid arthritis and dermatitis.” They added.

In the future, the TR-LSCI can be further optimized by using longer wavelength laser to obtain greater imaging depth and quality, or by using algorithms to improve the quality of the final image. This low-cost, high-resolution and complete non-invasive technique holds great potential to be widely used in clinical applications.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.